Bioequivalence Study on Loratadine Orally Disintegrating Tablets 10 mg Under Fasting Conditions
NCT00776217
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
80
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
loratadine 10 mg orally disintegrating tablets
Sponsor
Ranbaxy Laboratories Limited